Inventor · disambiguated record
Andre Lieber
Also filed as: LIEBER ANDRE · LIEBER ANDRÉ
19 granted patents·10 pending applications·195 citations·filing 1994–2023
94Inventor score
Files withUNIV WASHINGTON7UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION6MAX PLANCK GESELLSCHAFT4FRED HUTCHINSON CANCER CENTER3UNIV WASHINGTON CT COMMERCIALI2
Top patents by PatentIndex Score
29 records- 0195US10611803B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2018·Granted Apr 7, 2020·8 cites·15 claims
- 0292US10150798B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2017·Granted Dec 11, 2018·8 cites·20 claims
- 0389US9688727B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted Jun 27, 2017·8 cites·28 claims
- 0488US12466859B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2023·Granted Nov 11, 2025·0 cites·29 claims
- 0587US9200041B2Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)UNIV WASHINGTON CT COMMERCIALI·Filed 2013·Granted Dec 1, 2015·8 cites·19 claims
- 0684US7094398B1Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integrationUNIV WASHINGTON·Filed 2000·Granted Aug 22, 2006·20 cites·25 claims
- 0780US11820795B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2021·Granted Nov 21, 2023·0 cites·29 claims
- 0880US5980886ARecombinant vectors for reconstitution of liverUNIV WASHINGTON·Filed 1997·Granted Nov 9, 1999·47 cites·13 claims
- 0977US8722853B2Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)LIEBER ANDRE·Filed 2011·Granted May 13, 2014·5 cites·20 claims
- 1075US6686196B2Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereofUNIV WASHINGTON·Filed 2001·Granted Feb 3, 2004·13 cites·26 claims
- 1174US11248028B2Desmoglein 2 (DSG2) binding proteins and uses thereforUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2020·Granted Feb 15, 2022·0 cites·19 claims
- 1274US6107027ARibozymes for treating hepatitis CUNIV WASHINGTON·Filed 1995·Granted Aug 22, 2000·29 cites·19 claims
- 1366US6130092ARibozyme gene library and method for makingMAX PLANCK GESELLSCHAFT·Filed 1997·Granted Oct 10, 2000·23 cites·8 claims
- 1459US6107028ARibozymes for treating hepatitis CUNIV WASHINGTON·Filed 1996·Granted Aug 22, 2000·12 cites·38 claims
- 1558US2022229061A1Detection of desmoglein-2 in cancers of epithelial originHDT BIO CORP·Filed 2022·Application pending·0 cites
- 1658US2023313224A1Integration of large adenovirus payloadsFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1756US2023330185A1Methods and compositions for transducing hematopoietic stem and progenitor cells in vivoMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1854US2022257796A1Recombinant ad35 vectors and related gene therapy improvementsHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 1954US2023133243A1Conditioning regimens for in vivo gene therapyFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 2053US2022380776A1Base editor-mediated cd33 reduction to selectively protect therapeutic cellsFRED HUTCHINSON CANCER CENTER·Filed 2020·Application pending·0 cites
- 2148US6132989AMethods and compositions for enhanced stability of non-adenoviral DNAUNIV WASHINGTON·Filed 1997·Granted Oct 17, 2000·6 cites·11 claims
- 2247US2006281090A1Capsid-modified adenovirus vectors and methods of using the sameUNIV WASHINGTON UW TECH TRANSF·Filed 2004·Application pending·0 cites
- 2345US5695992AExpression cassette for antisense expression of ribozymeMAX PLANCK GESELLSCHAFT·Filed 1994·Granted Dec 9, 1997·6 cites·5 claims
- 2443US2015246949A1Desmoglein 2 (DSG2) Binding Proteins and Uses ThereforUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Application pending·0 cites
- 2535US2006073123A1Adenovirus vectors for immunotherapyMI JIE·Filed 2003·Application pending·0 cites
- 2633US5831067AAgent for stimulating animal cell divisionMAX PLANCK GESELLSCHAFT·Filed 1995·Granted Nov 3, 1998·2 cites·11 claims
- 2732USRE37411EExpression cassette for antisense expression of ribozymeMAX PLANCK GESELLSCHAFT·Filed 1998·Granted Oct 16, 2001·0 cites·5 claims
- 2831US8753639B2Compositions and methods for modulating the activity of complement regulatory proteins on target cellsLIEBER ANDRÉ·Filed 2010·Granted Jun 17, 2014·0 cites·30 claims
- 2931US2017037431A1In vivo Gene Engineering with Adenoviral VectorsUNIV WASHINGTON·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andre Lieber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →